Having dealt with issues like frequent urination, restless nights, and the discomfort caused by an enlarged prostate, ...

But even if you’re a person who hasn’t historically dealt with UTIs, you can run up against them in perimenopause because of ...

Three different bacteria were found in different dog food products. One is associated with kidney failure and neurologic ...

Retail chatter around Apellis Pharmaceuticals spiked Thursday after Goldman Sachs raised its price target to $26 from $24, citing strong quarterly performance and long-term growth potential through ...

Discover why many people may not be truly allergic to penicillin and how to determine your actual allergy status.

Targeted Oncology connects oncology professionals with updates on immunotherapy, biomarkers, cancer pathways, and targeted ...

A new study finds Medicare pays billions annually for low-value tests and treatments. See which procedures waste the most and ...

In July 2025, Novartis Pharmaceuticals announced a phase III study to assess efficacy and safety of crizanlizumab (5 mg/kg) ...

Reported positive topline data from open-label Phase 2 clinical trial of ATH434 in MSA Presented additional analyses from the ATH434-201 trial demonstrating continued robust efficacy for the treatment ...

Dementia with Lewy bodies (DLB), the second most common type of dementia, requires a multifactorial approach to reduce symptoms.

The Company received US FDA approval for the alfa pump System for the treatment of recurrent or refractory ascites due to liver cirrhosis in December 2024, following the grant of FDA Breakthrough ...